Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine

By Salleras L.   Domnguez A.   Cardenosa N.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 729-733

Elsevier

Access to resources Recommend Favorite

Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain

By Salleras L.   Domnguez A.   Cardenosa N.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 725-728

Elsevier

Access to resources Recommend Favorite

An outbreak of serogroup C meningococcal disease in the province of Antwerp (Belgium) in 2001–2002

By de Schrijver K.   Maes I.  

European Journal of Epidemiology, Vol. 18, Iss. 11, 2003-11 ,pp. : 1073-1077

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysis

By Parent du Chatelet I.   Gessner B.D.   da Silva A.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3420-3431

Elsevier

Access to resources Recommend Favorite

The effectiveness of serogroup C meningococcal vaccine estimated from routine surveillance data

By Rivest P.   Allard R.  

Vaccine, Vol. 20, Iss. 19, 2002-06 ,pp. : 2533-2536

Elsevier

Access to resources Recommend Favorite